Case Study on Square Pharma

In: Business and Management

Submitted By rockyuiu
Words 8546
Pages 35
The Lawyers & Jurists

Career
Upload Works
Monthly Journals
Set Up Business

Home
About Us
Our Lawyers
Our Clients
Services
Career
Online resources
Contact Us

Here you are: The Lawyers & Jurists > resources > Industries > Supply Chain Management SYSTEMS of SQUARE PHARMACEUTICALS LTD.
Supply Chain Management SYSTEMS of SQUARE PHARMACEUTICALS LTD.

view with images and charts
Supply Chain Management SYSTEMS of SQUARE PHARMACEUTICALS LTD.

Introduction:

Formally designed Commercial Department has been renamed as “Supply Chain Management” (SCM) in Mid July 2007. When only one Manager was guiding as Head of the Department but there was no gap for monitoring the officers’ activities. SCM started its journey with wider functions as a result it would divide into two folds –

Local Purchase

International Trade

Manager for the new section take responsibility to supervise activities more effectively and efficiently. Number of potential individuals have joined in SCM who are doing there jobs with total satisfaction. DGM is guiding works of both the sections and Executive Director (Admin) is monitoring & advising overall activities monitoring. SCM has recently generated new SOP considering present work volume and business environment. And DGM is getting to the point all out support and cooperation of Manager – International Trade and Manager – Local Purchase. Presently about 42 people are working in SCM.

SCM is the integrated part of some major objectives which are involved some functions and activities include cost-saving strategy, forecasting, purchasing, inventory management, information management, quality assurance, perfect scheduling, timely delivery, and vendors satisfaction.

SCM of all Organizations deals with supply on the basis of demand. The higher the demand, the higher the supply…...

Similar Documents

Square Pharma

... products? Square initially started their export with three types of products. • Anti-biotic • Vitamin • Anti-Alser (neotec, seclo) ➢ Did Square use any intermediaries? They had used intermediaries like bank, shipping. ➢ What are the home and host country obstacles? Square pharmaceuticals had faced a lot of obstacles in both home and host country. In the home country they have problem regarding- • Poor country image. Square says that this is their biggest obstacles in exporting. • Lack of knowledge about marketing of pharmaceuticals products in international market. • Stringent (severe) or inflexible monitory policy. • Lack of proper infrastructure. • Unstable political environment. In host country they have experienced some difficulties concerning these issues like • Non-tariff barriers (like poor country image) • Lack of bi-lateral trade agreements. • Absence of Bangladeshi embassy in that country. In this case Square has to enter in the market with the help of India. ➢ How did you ship your product? Square ship their product by using the three medium air, sea and road. It depends on the in which country they are exporting. ➢ Which C&F agent, insurance company, and banks do they use? • C&F Agent- Khan Traders. • Insurance company- Pioneer insurance. • Bank- Standard...

Words: 971 - Pages: 4

Square

...SQUARE Have you heard about the new “Square”? As in, “Are we square?” It’s a new square-shaped gizmo that gives people a way to accept credit card payments on their iPhone, iPad, or Android. It was invented by Jack Dorsey, the founder of Twitter, a guy who knows something about new ideas that catch on with people carrying cell phones. Prior to this, really only business owners could accept credit card payments. A standard credit card machine costs several hundred dollars, and credit card processing companies charge set-up fees and monthly fees (whether you make any charges or not), as well as high per-transaction fees to boot. That’s why ordinary folks don’t own a credit card machine. According to its Web site, the small Square device is free and plugs into the earphone jack, the downloadable app for it is free, there are no set-up or monthly fees, and the per-transaction costs are much lower. It’s secure, it E-mails the receipts, and it keeps track of all your cash and credit card transactions for you.  The New York Times calls the idea “beautiful, simple, and a joy to use.” Add to that “disruptive, brilliant, and irresistible.” Disruptive? You bet. Not only is every kid with a lemonade stand--and every Tupperware lady and every cab driver and plumber--now going to be able to take credit and debit cards, big companies like department stores and chain restaurants would be crazy not to switch for the lower fees and free equipment. The credit card companies are not going...

Words: 604 - Pages: 3

Strategy Square Pharma

... & patients already, it occupies a good position it their minds. * High quality products Square maintains high quality standards for its products, that why it enjoys a good position in the market. * World class manufacturing facilities. SPL has very high quality manufacturing facilities which enable SPL to export its products in the global market. 3.1.2 WEAKNESSES: The chain of command of Square is elongated, which takes long time to take any decision. In reality Square has insignificant weakness in strategy * Need more smooth distribution channel * Lack of ability to compete with the MNCs SPL is lack the ability to compete with MNCs for New Drug Discovery, Research and commercialization of molecules on a worldwide basis due to lack of resources. * In case of product launching Square is follower rather than to become pioneer. In some cases like, introduction of the Omeprazole Injection, SPL is market follower rather than market pioneer. * Inadequate Sales and marketing knowledge Sales and marketing knowledge is inadequate due to lack of understanding of international Pharmaceutical marketing/pricing practices and market environment in various countries. 3.1.3 OPPORTUNITIES: The pharmaceutical market of Bangladesh is booming rapidly, so Square has a huge scope to do better. * Today technology is more advanced and sophisticated which opens the door of the new generation of medicine. * More and more health care centers and hospital are...

Words: 3682 - Pages: 15

Financial Analysis of Square Pharma

...Institute of Business Administration (IBA) MBA Admission Test 50th Batch ( Session 2012 – 2013 ) MBA Admission Test (2012 – 13) of the Institute of Business Administration (IBA), University of Dhaka will be held on Friday, June 14, 2013 at 10 am. For all other certificates, equivalence will be determined by the Equivalence Committee of IBA. ELIGIBILITY All applicants must have at least a Bachelor Degree in any field of study. The minimum qualifying point is seven (07) for all applicants. The points are calculated as follows: SELECTION PROCEDURE The test has two components: Written Assessment and Interview. The written assessment component evaluates applicants’ aptitude in Language, Mathematics, and Analytical ability. An applicant must obtain a minimum qualifying score in each of the above areas to pass of the written test and appear for the interview. All Bangladeshi applicants must take the admission test. An applicant with foreign nationality with minimum 70 percentile in GMAT may be exempted from the written assessment. However, they will be required to appear for an interview. SSC and HSC or Equivalents SSC GPA/Div >= 4.0/Ist >= 3.0/2nd >= 1.0/3rd HSC GPA/Div >= 4.0/Ist >= 3.0/2nd >= 1.0/3rd O-level GPA A-level GPA Points Earned 3 2 1 * * >= 3.0 >= 2.5 >= 1.0 >=2.5 >= 2.0 >= 1.0 Applicants who have taken O-Level examination must pass at least five (05) subjects (including mathematics) with a minimum of grade D in each of the subjects...

Words: 458 - Pages: 2

Pharma

... of Health in Saudi Arabia signed an agreement with Tamer Group to run an awareness program on non-communicable diseases across the country.  In January 2012, the company signed an agreement to sell 500,000 square meters of freehold land in the Industrial Valley at King Abdullah Economic City to Emaar, The Economic City. GCC Pharmaceutical Sector | March 31, 2013 Page | 72 Yassen United Group (Privately Owned) Company Description Saudi Arabia Yassen United Group was established in 1990 and is engaged in the distribution of pharmaceutical products, medical equipment, and cosmetics through a chain of stores across Saudi Arabia. The group operates through three companies, United Pharmaceuticals Est., Mohammed Abdulraheem Yassen & Co., and Manayer Najd Trading & Medical Supply Co. LLC. As of March 2012, the group operated five branches and 225 pharmacies spread across the kingdom. Business Segments/Product Portfolio Yassen United Group operates through the following companies:  United Pharmaceuticals Est. (UPE): Established in 1990, UPE runs a chain of pharmacy stores across Saudi Arabia selling pharmaceutical products, medical equipments, and cosmetics. UPE also distributes products on a wholesale basis to private, government & military hospitals, polyclinics, and pharmacies across the kingdom. Some of the suppliers of UPE include Bio Product Laboratory (UK), Antiseptica (Germany), Sterisol (Sweden), and Mid Pharma (Jordan).  Mohammed Abdulraheem Yassen...

Words: 27542 - Pages: 111

Performance Dynamics of an Industrial Enterprise in Bangladesh a Case Study of Beximco Pharma

...Introduction: Beximco Pharmaceuticals Ltd. Since its inception in 1979 has continued with its relentless strive to maintain leadership position in the Bangladesh Pharmaceutical Industry even in the new millennium. The healthcare welfare of the society remains to be their uncompromising objective. They  provide the highest quality medicines at an affordable price to cater to the needs of the millions of people of the country. Regular introduction of innovative products in line with the needs of their customers have been the key to the company’s success over the years.  Ever since the start of our journey in late seventies they  have successfully maintained the quality of their products throughout, thereby earning the trust and faith of the society. Ingenious approaches on manufacturing, R&d and marketing remain the strategic objective during 2010 and beyond.  Origin of The Study: This report will be prepared as a part of the internship program which is an integral part of the BBA program under the Dept. of Accounting & Information Systems in the Faculty of Business Studies, University of Dhaka. The organization attachment was started on 18th July, 2010. This report on “Financial Performance Analysis of Beximco pharmaceuticals Ltd(BPL)” was assigned by academic supervisor Mohammad Moniruzzaman,ACA, Lecturer of Dept of Accounting & Information Systems, Faculty of Business Studies, University of Dhaka. Purpose of The Study: The purpose of the study is to make...

Words: 11192 - Pages: 45

Financial Growth of Square Pharma

...: Submission of the Report. Dear Madam, Here is the Report on Performance of Square Pharmaceuticals Ltd based on the year 2006-2007 Which we the group members studied. We have tried our best to prepare the report in consistence with the optimal standard under your valuable direction. We would be very grateful if you accept our report modestly as it may suffer from some shortcomings. We desired and endeavored to make this paper a complete one. Therefore, we hope that this will meet the standard of your judgment. Thank you again for your heartiest co-operation. Sincerely yours Group No – 05 Section – 01 Course Code – Bus 104 Course Title – Introduction to Finance ULAB School of Business University of Liberal Arts Bangladesh Dated: December 9th, 2007 TABLE OF CONTENTS Page No Introduction • Preface • Objectives of the Study • Methodology • Limitation of the Study Corporate Review • Corporate History • Mission & vision • Ten Principles • Management Apparatus...

Words: 4202 - Pages: 17

Case Study on Square Pharma

.... SCM is the integrated part of some major objectives which are involved some functions and activities include cost-saving strategy, forecasting, purchasing, inventory management, information management, quality assurance, perfect scheduling, timely delivery, and vendors satisfaction. SCM of all Organizations deals with supply on the basis of demand. The higher the demand, the higher the supply activities are. 1.2 Why Supply Chain management is needed? A number of factors made it desirable for Square Pharmaceuticals to manage SCM actively. Major factors are: Need to improve operational activities Need to increase the level of outsourcing Need to manage inventories more effectively Ensure to meet up demand in time Decrease transportation cost & supply risk Above factors help SCM to be effective include lower cost, lower inventories, higher productivity, shorter lead time, higher profits and greater customer loyalty. 1.3 Requirement for a successful Successful SCM required trust among the team members, effective communication, Supply Chain visibility, event management capability, problem solving power, leading power, and performance merits. Trust: It is essential in every manufacturing organization SCM to build trust among each other, and feel confident, will take such decisions that would make ultimate benefit. Effective communication: Effective SCM requires integrated technology and standardized ways and means of communicating among......

Words: 8546 - Pages: 35

Square

... blown production. Although the company guidance was for production to start before 2010, it has been delayed. We expect these two to start production properly in 2011 and add to consolidated revenue. SPL management seems to be hoping that it will eventually be able to list its subsidiaries. Square Square Textiles, an associate of Square Pharma and a former subsidiary, is now a listed company. Investment in Square Textiles was BDT 183 million on a cost basis and current market value of this investment is more than BDT 12 billion. SPL expects that in time it will be able to list its current subsidiaries in the capital market, allowing it to monetize its investment. The company’s operating cash flow is higher than its total capital expenditure, which includes expansion and maintenance. Therefore we assume major portion of investing activity to be financed internally. This results in a very low debt to equity ratio. Existing subsidiaries may present excellent capital gain opportunity 8 Square Pharmaceuticals (DSE: SQURPHARMA; Bloomberg: SQUARE:BD) Valuation Since Square Pharmaceuticals is involved in a number of subsidiaries and associate companies, a Sum-of-the-Parts (SOTP) valuation appears to be more relevant. We derive value per share for each of these companies using various valuation methodologies depending on the type of business and its relationship with the parent company. We use DCF valuation for Square Pharmaceutical’s standalone business as well as Square...

Words: 5647 - Pages: 23

Xyz Pharma Case

... Davida Franklin SCMS 3711 M50 M.Cervetti XYZ Critical Thinking Project Part 1- Framing the Project Portfolio Management Problem 1. What are the objectives? The objective is to research and develop pharmaceuticals products based on the selections that minimize cost and maximize value and sales. There will be a discussion of which projects will be allocated additional resources and at what cost. 2. What are the constraints? Competition is usually between brand-name drugs. Constraints for the study include risky drug discovery and development which could cause harm to participants and also waste money used on development. Other restrictions include the amount of time spent on Research and Development which leads to increased costs. There is also the concern with low return on investments and the emergence of generic drugs and competitors. 3. What are the risks involved? There are both technical and commercial risks involved. The most risky aspect of the project is within the research and development process. Drug discovery and development is extremely risky, time-consuming, and expensive. Millions of dollars are spent in the R& D process and many of the drugs created do not make it past the Basic Research stage. The risks associated with low return on investment or no return at all on the investment pose a big risk for pharmaceutical companies. 4. What are your alternatives? The company can choose to allocate resources to other projects or services besides......

Words: 338 - Pages: 2

Financial Analysis of Square Pharma

... be rise in cost of production, administrative cost, financial cost etc. * The liquidity position of the company is satisfactory. The company’s current ratio and quick ratio is in a fluctuating trend, but the ratio remains good on year 2013. The liquidity ratios show that they have very alarming condition for meeting the outside liabilities from their current assets. * Gearing is the ability of a company to increase the Earning Per share (EPS) by using debt capital. Square Pharmaceuticals Ltd. is using more equity capital than the long-term debt capital but it is bad sign that the debt is decreasing from year to year, in terms of leverage ratio. * Efficiency ratios are impressive in case of Square Pharmaceuticals Ltd. Analysis indicates that the credit management policy of SPL is satisfactory and inventory turnover indicates the increase of net income of the firm. * The Price Earning Ratio of the industry indicates that how much the invested is ready to offer against EPS. The market measure position of SPL is unsatisfactory due to decreasing price earning ratio. Question# 4 A description of the movement in each of the ratios for Square and an explanation of what this movement tells you about Square: Current Ratio: The ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities (debt and payables) with its short-term assets (cash, inventory, receivables). The higher the current ratio, the more capable the company is...

Words: 4003 - Pages: 17

Financial Statement Analysis of Square Pharma

...INTRODUCTION: Objectives of the Report: 1. To know the current financial performance of the two companies. 2. To know the future prospect of the companies. 3. To compare the financial position of the two companies. Scope of the report: 1. Studying the pros and cons of the financial statements of a company, it is possible to predict the probable future growth of a company Methodology: Data were collected from Annual Reports of Square Pharmaceuticals Ltd. and Renata Pharmaceuticals Ltd. from the year 2003 to 2008. Three types of financial tools were used to analyze the data which are: 1. Horizontal Analysis 2. Vertical Analysis and 3. Ratio Analysis. LITERATURE REVIEW: Financial Analysis: The art of transforming data from financial statements into information that is useful for informed decision making is financial analysis. Financial analysis involves the use of various financial statements. These statements do several things.  First the balance sheet summarizes the assets, liabilities and owners’ equity of a business at a moment in time usually the end of a year or a quarter. Next the income statement summarizes the revenue and expenses of the firm over a particular period of time, again usually a year or a quarter. Need for Comparative Analysis: Every item reported in a financial statement has significance. We know a company had a certain amount of cash on the balance sheet but we do not know whether the amount represents an increase over prior...

Words: 1445 - Pages: 6

Square Pharma

...1. Origin of the report Our honorable course instructor Afreen Choudhury has assigned us to prepare a term paper on job analysis (job description and job specification), forecast the required number of applicants, select the appropriate sources of candidates, choose the relevant test method, organize the questionnaire for interview, set strategic pay plan and benefits and Services (Safety and Health) for a particular job post with the help of supervisor and HR manager of any company. We have chosen Square Pharmaceutical Ltd and the job post on which we have prepared our report is Medical Promotion Officer. We visited Square Pharmaceuticals Limited. There we appointed with Mr. Younus Ali (Sr. Manager, HRD) and Mr. Tamim Ahsan( Territory officer in Dhaka region). They were very cordial and helpful to us share their experience and provide the required information as they can provide within the policy. We asked them different relevant questions and information to provide. 1.1. Profile of Square Pharmaceuticals Ltd. Corporate Headquarters | : SQUARE CENTRE 48, Mohakhali Commercial Area Dhaka 1212, Bangladesh | Factory | : Shalgaria, PabnaTown, Pabna | Established | :1958 | Constitution | : Public Ltd Company | Founder Chairman | : Mr. Samson H Chowdhury | Chairman | : Mr. Samuel S Chowdhury | Managing Director | : Mr. Tapan Chowdhury | Details of Business | : 1. Pharmaceuticals Products 2. Bulk Chemicals 3. AgroVet Products | Manufacturing Units | :1...

Words: 2745 - Pages: 11

Financial Ratio Analysis of Square Pharma & Beximco Pharma

...|Financial Ratio Analysis | | | |Performing Year: 2008 & 2009 | | | | Beximco Pharmaceuticals ltd. & Square Pharmaceuticals ltd. Submitted by Group Name: Peace Messengers • Islam Mohammad Samiul (09-14649-3) • Hamid Faisal (09- 15037 -3) Course Name: Financial Management Section: H AIUB Letter of Transmittal 01/03/2011 Mrs. Farzana Islam Honorable Faculty A.I.U.B. Dear Madam, It gives us immense pleasure to submit a report on “Financial Ratio Analysis”. This report is submitted as a partial fulfillment/ as a part of our course “Financial Management ”. We have choose two renowned pharmaceuticals companies of the country who are “Beximco Pharmaceuticals Ltd.” and “Square Pharmaceuticals Ltd.”The preparation of the report has given us in-depth knowledge on “Financial Ratio Analysis”. We have given our best effort to make it a worthy one and each aspect of the problem is considered and studied as required. If any confusion arises or further explanation is needed, we shall be available to explain the matter to you as and when required despite having limitations. Your compassionate and...

Words: 2113 - Pages: 9

Square Pharma Business Report

...[pic] [pic] [pic] EXECUTIVE SUMMARY Square Pharmaceutical Limited Bangladesh is one of the leading pharmaceuticals in Bangladesh. SQUARE today symbolizes a name – a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player. Their Future Focus are- • Strengthen its position in the present markets. • Work is in progress to enter into regulated markets in Europe and United States. In this report, we have tried to show you the actual business environment of Square Pharmaceutical Limited Bangladesh. In details we have included company’s basic profile, its annual business report and the background of the organization. CONTENT • Company Profile 5 • Square Pharmaceuticals Ltd. 6-23 • Management 7 • Square Quality Policy 9 • Financial Report 10-17 • Their Products...

Words: 2256 - Pages: 10